Back to Journals Diabetes, Metabolic Syndrome and Obesity Volume 18 Appendicitis After Initiation of Tirzepatide Authors Chan G , Ansar M, Klein M Received 9 October 2024 Accepted for publication 15 January 2025 Published 31 January 2025 Volume 2025:18 Pages 261265 DOI Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 4 Editor who approved publication: Dr Halis Akturk Garrett Chan 1 , Mariam Ansar 1 , Marlena Klein 1,2 1 Department of Internal Medicine, Cooper University Hospital, Camden, New Jersey, USA
Bacteriostatic Water for Injection, USP Product Information
It is the first drug that is made from glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide-1 (GLP-1) receptor agonist, which are used to treat type 2 diabetes mellitus as a single therapy or with other diabetes medicines [1]
K.QianY.MillJ.JamesI.et al